Harrington Investments’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.8M | Sell |
9,565
-183
| -2% | -$87.8K | 2.32% | 10 |
|
|
2026
Q1 | $4.79M | Buy |
9,748
+100
| +1% | +$54.3K | 2.52% | 11 |
|
|
2025
Q4 | $5.59M | Sell |
9,648
-219
| -2% | -$124K | 2.81% | 9 |
|
|
2025
Q3 | $4.79M | Sell |
9,867
-72
| -0.7% | -$33.5K | 2.39% | 11 |
|
|
2025
Q2 | $4.03M | Sell |
9,939
-64
| -0.6% | -$26.8K | 2.13% | 12 |
|
|
2025
Q1 | $4.98M | Sell |
10,003
-46
| -0.5% | -$24.9K | 2.83% | 9 |
|
|
2024
Q4 | $5.23M | Sell |
10,049
-112
| -1% | -$61.6K | 2.87% | 9 |
|
|
2024
Q3 | $6.29M | Sell |
10,161
-43
| -0.4% | -$25.5K | 3.43% | 4 |
|
|
2024
Q2 | $5.64M | Sell |
10,204
-495
| -5% | -$284K | 3.2% | 5 |
|
|
2024
Q1 | $6.22M | Sell |
10,699
-178
| -2% | -$99.9K | 3.56% | 3 |
|
|
2023
Q4 | $5.77M | Sell |
10,877
-285
| -3% | -$138K | 3.58% | 3 |
|
|
2023
Q3 | $5.65M | Sell |
11,162
-128
| -1% | -$68.2K | 3.89% | 3 |
|
|
2023
Q2 | $5.89M | Sell |
11,290
-282
| -2% | -$152K | 3.86% | 3 |
|
|
2023
Q1 | $6.67M | Sell |
11,572
-107
| -0.9% | -$60.3K | 4.6% | 3 |
|
|
2022
Q4 | $6.43M | Sell |
11,679
-509
| -4% | -$270K | 4.65% | 3 |
|
|
2022
Q3 | $6.18M | Buy |
12,188
+4
| +0% | +$2.24K | 4.81% | 3 |
|
|
2022
Q2 | $6.62M | Sell |
12,184
-966
| -7% | -$532K | 4.92% | 3 |
|
|
2022
Q1 | $7.77M | Sell |
13,150
-30
| -0.2% | -$17.2K | 4.65% | 3 |
|
|
2021
Q4 | $8.79M | Sell |
13,180
-285
| -2% | -$178K | 4.73% | 4 |
|
|
2021
Q3 | $7.69M | Sell |
13,465
-72
| -0.5% | -$39.5K | 4.44% | 4 |
|
|
2021
Q2 | $6.83M | Buy |
13,537
+86
| +0.6% | +$40.6K | 4.04% | 6 |
|
|
2021
Q1 | $6.14M | Sell |
13,451
-104
| -0.8% | -$49.6K | 3.84% | 6 |
|
|
2020
Q4 | $6.31M | Sell |
13,555
-716
| -5% | -$336K | 4.2% | 5 |
|
|
2020
Q3 | $6.3M | Sell |
14,271
-212
| -1% | -$87.6K | 4.46% | 3 |
|
|
2020
Q2 | $5.25M | Sell |
14,483
-427
| -3% | -$143K | 4.09% | 3 |
|
|
2020
Q1 | $4.23M | Sell |
14,910
-280
| -2% | -$88.3K | 3.96% | 4 |
|
|
2019
Q4 | $4.93M | Sell |
15,190
-124
| -0.8% | -$37.6K | 3.82% | 4 |
|
|
2019
Q3 | $4.46M | Sell |
15,314
-133
| -0.9% | -$38.1K | 3.68% | 3 |
|
|
2019
Q2 | $4.54M | Buy |
15,447
+5
| +0% | +$1.38K | 3.73% | 2 |
|
|
2019
Q1 | $4.23M | Buy |
15,442
+87
| +0.6% | +$21.7K | 3.64% | 3 |
|
|
2018
Q4 | $3.44M | Sell |
15,355
-87
| -0.6% | -$20.4K | 3.3% | 3 |
|
|
2018
Q3 | $3.77M | Sell |
15,442
-235
| -1% | -$54.1K | 2.99% | 5 |
|
|
2018
Q2 | $3.25M | Sell |
15,677
-545
| -3% | -$116K | 2.75% | 5 |
|
|
2018
Q1 | $3.35M | Sell |
16,222
-262
| -2% | -$55K | 2.75% | 5 |
|
|
2017
Q4 | $3.13M | Buy |
16,484
+323
| +2% | +$61.9K | 2.61% | 7 |
|
|
2017
Q3 | $3.06M | Buy |
+16,161
| New | +$2.93M | 2.92% | 5 |
|
Other funds holding TMO
RG
ECSS
LT
Harrington Investments's TMO Position: Q2 2026 in Review
Harrington Investments reduced its Thermo Fisher Scientific (TMO) stake by 1.9% in Q2 2026, selling an estimated $87.8K and leaving 9,565 shares worth $4.8M. The position accounts for 2.32% of the portfolio, ranked #10.
Harrington Investments first reported a position in TMO in Q3 2017 and has held it in 36 quarters since. The position peaked at $8.79M in Q4 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Harrington Investments held 9,565 shares of Thermo Fisher Scientific worth $4.8M as of Q2 2026.
- Harrington Investments sold 183 Thermo Fisher Scientific shares in Q2 2026, an estimated $87.8K.
- Thermo Fisher Scientific made up 2.32% of Harrington Investments's portfolio in Q2 2026, its #10 holding.
- Harrington Investments first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 36 quarters since.
- Harrington Investments's Thermo Fisher Scientific position peaked at $8.79M in Q4 2021.
- 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Harrington Investments's 13F filing for Q2 2026, filed 23 Jul 2026.